<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04651998</url>
  </required_header>
  <id_info>
    <org_study_id>CAS-fNIRS</org_study_id>
    <nct_id>NCT04651998</nct_id>
  </id_info>
  <brief_title>Effect of Carotid Artery Stent on Evoked Cerebral Blood Oxygenation and Neurocognitive Functioning</brief_title>
  <official_title>Effect of Carotid Artery Stent on Evoked Cerebral Blood Oxygenation and Neurocognitive Functioning</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Minhang Hospital, Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ShuGuang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cerebral hemodynamic compromise from internal carotid artery stenosis may be a cause of&#xD;
      vascular cognitive impairment that is amenable to treatment by revascularization. The effect&#xD;
      of carotid artery stent on evoked cerebral blood oxygenation and neurocognitive functioning&#xD;
      will be evaluated by functional near-infrared spectroscopy. Carotid artery stent could&#xD;
      benefit cerebral blood oxygenation after stent and improving neurocognitive functioning after&#xD;
      6 months.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with high grade internal carotid artery stenosis intended to carotid artery stent&#xD;
      are brought to this study. Global cognitive function and evoked cerebral blood oxygenation&#xD;
      are evaluated before and after stent, followed up at 6 months later. Mini-Mental State&#xD;
      Examination(MMSE) and Montreal Cognitive Assessment (MoCA) are used for the global cognitive&#xD;
      test. Evoked cerebral blood oxygenation is evaluated using functional near-infrared&#xD;
      spectroscopy(fNIRS) through performing mental task( N-back task, Go/no go task, and verbal&#xD;
      fluency task ). All the patients from different centers are conducted the test at the only&#xD;
      main center by one doctor. The parameter of fNIRS and score of cognitive test of each patient&#xD;
      are compared before and after stent.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Change of cognitive function score</measure>
    <time_frame>MMSE score at baseline, 6 months after revascularization. Change of the score is calculated.</time_frame>
    <description>Mini-mental State Examination (0-30 points), the higher the score, the better the cognitive function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Parameter of evoked cerebral blood oxygenation</measure>
    <time_frame>Evoked cerebral blood oxygenation evaluated after stent immediately, 6 months later, compared with that at baseline.</time_frame>
    <description>Means of HbO detected by functional near-infrared spectroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parameter of evoked cerebral blood oxygenation</measure>
    <time_frame>Evoked cerebral blood oxygenation evaluated after stent immediately, 6 months later, compared with that at baseline.</time_frame>
    <description>Skewness of HbO detected by functional near-infrared spectroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parameter of evoked cerebral blood oxygenation</measure>
    <time_frame>Evoked cerebral blood oxygenation evaluated after stent immediately, 6 months later, compared with that at baseline.</time_frame>
    <description>kurtosis of HbO detected by functional near-infrared spectroscopy</description>
  </secondary_outcome>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Carotid Artery Stenosis</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>MMSE, MoCA, functional near-infrared spectroscopy</intervention_name>
    <description>MMSE and MoCA are used for cognitive test before carotid artery stent implant and 6 months later. Cerebral blood oxygenation is evaluated by functional near-infrared spectroscopy under the mental task before and after revascularization within one week, 6 months later respectively.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with high grade carotid artery stenosis treated with carotid artery stent from 5&#xD;
        hospitals.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 35-80 years old&#xD;
&#xD;
          2. Severe carotid stenosis (MRA or CTA confirmed stenosis rate of 70% - 99%, NASCET&#xD;
             standard)&#xD;
&#xD;
          3. Asymptomatic or mild stroke (NIHSS â‰¤ 3) or TIA&#xD;
&#xD;
          4. Agree to participate in the clinical trial and sign the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Severe stenosis or occlusion of vertebrobasilar artery and other intracranial arteries&#xD;
             (70% - 99%)&#xD;
&#xD;
          2. Left ventricular ejection fraction &lt; 50% or heart failure&#xD;
&#xD;
          3. Other types of dementia have been diagnosed&#xD;
&#xD;
          4. Severe depression, mental illness, epilepsy&#xD;
&#xD;
          5. Not cooperating with cognitive task evaluation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yueqi Zhu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jiangshan Deng, PhD</last_name>
    <phone>862164369181</phone>
    <email>johnson120@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai 6th People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>200023</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yue-Qi Zhu, Dr.</last_name>
      <phone>0086-021-64844183</phone>
      <email>zyq1111@126.com</email>
    </contact>
    <investigator>
      <last_name>Yue-Qi Zhu, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 24, 2020</study_first_submitted>
  <study_first_submitted_qc>December 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2020</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</investigator_affiliation>
    <investigator_full_name>Yueqi Zhu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>carotid artery stent, functional near-infrared spectroscopy, vascular cognitive impairment,</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

